Related Experiment Video
Updated: Jan 12, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Radiotherapy Planning for Nasopharyngeal Carcinoma After Induction Chemotherapy: A Systematic Review to Inform
Omar Nouri1, Ryan Anthony Agas2,3, Lester Bryan Co4
1Department of Radiation Oncology, University of Sfax - Faculty of Medicine, EPS Habib Bourguiba, Sfax, Tunisia.
Consensus is lacking on radiotherapy after induction chemotherapy for advanced nasopharyngeal carcinoma. This review highlights practice variations in target volumes and doses, underscoring the need for international guidelines.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Guidelines
Background:
- Induction chemotherapy (ICT) followed by chemoradiotherapy is standard for locoregionally advanced nasopharyngeal carcinoma (LA-NPC).
- Significant practice variations exist regarding radiotherapy (RT) after ICT.
- There is a need to harmonize RT practices for LA-NPC.
Purpose of the Study:
- To systematically review current literature on RT practices post-ICT for LA-NPC.
- To identify areas of significant practice variation in RT target volumes and prescriptions.
- To inform the development of international consensus guidelines.
Main Methods:
- A scoping review was conducted to identify practice differences.
- A systematic review followed to analyze existing literature.
- Expert committees (Steering Committee and Evidence Review Committee) comprising radiation oncologists were involved.
Main Results:
- Significant practice variations identified in RT timing, imaging modalities, dose prescription, and target volume delineation post-ICT.
- No specific recommendations found for optimal post-ICT RT timing or imaging modalities.
- Evidence suggests potential for volume reduction in RT targets without compromising outcomes, possibly improving quality of life.
Conclusions:
- A lack of evidence and established guidelines exists for post-ICT RT timing and imaging in LA-NPC.
- Divergent guidelines on post-ICT target volumes and dose levels are prevalent, with limited clinical trial data.
- International consensus guidelines are essential to standardize RT practices for LA-NPC.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

